American International Group, Inc. Aravive, Inc. Transaction History

American International Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$4.65 - $6.42 $32,949 - $45,492	-7,086 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$5.11 - $9.24 $97 - $175	19 Added 0.27%	7,086 $47,000
Q4 2020 Feb 12, 2021	SELL	$4.36 - $6.51 $885 - $1,321	-203 Reduced 2.79%	7,067 $40,000
Q3 2020 Nov 04, 2020	SELL	$4.7 - $12.06 $784 - $2,014	-167 Reduced 2.25%	7,270 $34,000
Q2 2020 Aug 12, 2020	BUY	$5.18 - $14.81 $38,523 - $110,141	7,437 New	7,437 $87,000

28.1K

Ticker ARAV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,518,300
Description
Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.